Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""DE Moraes Filho MO"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-13 z 13
    Tytuł:
    PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.
    Autorzy:
    Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    da Silva EL; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Ferreira WAS; Laboratory of Cytogenomics and Environmental Mutagenesis, Environment Section (SAMAM), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.
    Pessoa FMCP; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Quadros AU; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Fantacini DMC; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Furtado IP; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Rossetti R; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Silveira RM; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    de Lima SCG; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Mello Júnior FAR; Molecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.
    Seabra AD; Molecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.
    Moreira ECO; Institute of Health and Biological Studies, Federal University of the South and Southeast of Pará, Marabá 68501-970, PA, Brazil.
    de Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Montenegro RC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
    Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Burbano RMR; Molecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    de Oliveira EHC; Laboratory of Cytogenomics and Environmental Mutagenesis, Environment Section (SAMAM), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.
    Covas DT; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    de Souza LEB; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
    Moreira-Nunes CFA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, CE, Brazil.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Nov 22; Vol. 15 (23). Date of Electronic Publication: 2023 Nov 22.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives.
    Autorzy:
    Barreto IV; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Machado CB; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Almeida DB; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.
    Pessoa FMCP; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Gadelha RB; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Pantoja LDC; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Oliveira DS; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
    Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza 60015-152, CE, Brazil.
    de Moraes Filho MO; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Moraes MEA; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    de Oliveira EHC; Faculty of Natural Sciences, Institute of Exact and Natural Sciences, Federal University of Pará (UFPA), Rua Augusto Correa, 01, Belém 66075-990, PA, Brazil.; Laboratory of Cytogenomics and Environmental Mutagenesis, Environment Section (SAMAM), Evandro Chagas Institute (IEC), BR 316, KM 7, s/n, Levilândia, Ananindeua 67030-000, PA, Brazil.
    Moreira-Nunes CA; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, CE, Brazil.
    Pokaż więcej
    Źródło:
    Pharmaceutics [Pharmaceutics] 2022 Aug 25; Vol. 14 (9). Date of Electronic Publication: 2022 Aug 25.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.
    Autorzy:
    Sanford ABA; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.
    da Cunha LS; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.
    Machado CB; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Pinho Pessoa FMC; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Silva ANDS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
    Moreira FC; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    de Moraes Filho MO; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Moraes MEA; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Souza LEB; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, São Paulo 14051-140, SP, Brazil.
    Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Moreira-Nunes CA; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, CE, Brazil.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 Jul 26; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 26.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Chronobiology Disorders*
    Circadian Clocks*/genetics
    Leukemia*/genetics
    Neoplasms*
    Biomarkers ; Circadian Rhythm/genetics ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach.
    Autorzy:
    Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    da Cunha LS; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.
    Maués JHDS; Hematology and Transfusion Medicine Center, University of Campinas, Campinas 13083-970, SP, Brazil.
    Pessoa FMCP; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Oliveira MB; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
    Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza 60015-152, CE, Brazil.
    de Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    de Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
    Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.
    Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Unichristus University Center, Faculty of Biomedicine, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Department of Health Sciences, Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, CE, Brazil.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 May 14; Vol. 23 (10). Date of Electronic Publication: 2022 May 14.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    HTLV-I Infections*/genetics
    Leukemia-Lymphoma, Adult T-Cell*/genetics
    Leukemia-Lymphoma, Adult T-Cell*/virology
    MicroRNAs*/genetics
    Computational Biology ; Human T-lymphotropic virus 1 ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.
    Autorzy:
    de Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    da Silva EL; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    da Costa Pantoja L; Department of Pediatrics, Octávio Lobo Children's Hospital, Belém 60430-275, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, Brazil.
    de Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    de Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    Montenegro RC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.
    Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, Brazil.
    Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, Brazil.; Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, Brazil.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 Mar 30; Vol. 23 (7). Date of Electronic Publication: 2022 Mar 30.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Neoplasms*/drug therapy
    Neoplasms*/pathology
    Cytotoxins/therapeutic use ; Drug Delivery Systems ; Humans ; Immunologic Factors/therapeutic use ; Immunotherapy/methods ; Molecular Targeted Therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.
    Autorzy:
    Machado CB; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    de Pinho Pessoa FMC; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    da Silva EL; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    da Costa Pantoja L; Department of Pediatrics, Octávio Lobo Children's Hospital, Belém 60430-275, Brazil.; Oncology Research Center, Department of Biological Sciences, Federal University of Pará, Belém 66073-005, Brazil.
    Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, Brazil.
    de Moraes Filho MO; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    de Moraes MEA; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    Montenegro RC; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.
    Burbano RMR; Oncology Research Center, Department of Biological Sciences, Federal University of Pará, Belém 66073-005, Brazil.
    Khayat AS; Oncology Research Center, Department of Biological Sciences, Federal University of Pará, Belém 66073-005, Brazil.
    Moreira-Nunes CA; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Department of Medicine, Federal University of Ceará, Fortaleza 60430-275, Brazil.; Oncology Research Center, Department of Biological Sciences, Federal University of Pará, Belém 66073-005, Brazil.
    Pokaż więcej
    Źródło:
    Pharmaceutics [Pharmaceutics] 2021 Oct 02; Vol. 13 (10). Date of Electronic Publication: 2021 Oct 02.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia.
    Autorzy:
    Moreira-Nunes CA; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil. .
    Mesquita FP; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil.
    Portilho AJS; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil.
    Mello Júnior FAR; Molecular Biology Laboratory, Ophir Loyola Hospital, Belém, PA, Brazil.
    Maués JHDS; Laboratory of Human Cytogenetics, Institute of Biological Sciences, Federal University of Pará, Belém, PA, Brazil.
    Pantoja LDC; Department of Pediatrics, Octávio Lobo Children's Hospital, Belém, PA, Brazil.
    Wanderley AV; Department of Pediatrics, Octávio Lobo Children's Hospital, Belém, PA, Brazil.
    Khayat AS; Oncology Research Center, João de Barros Barreto University Hospital, Federal University of Pará, Belém, PA, Brazil.
    Zuercher WJ; Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, Chapel Hill, NC, USA.
    Montenegro RC; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil.
    de Moraes-Filho MO; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil.
    de Moraes MEA; Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Coronel Nunes de Melo st, n 1000, Rodolfo Teófilo, Fortaleza, CE, CEP: 60416-000, Brazil.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Dec 04; Vol. 10 (1), pp. 21272. Date of Electronic Publication: 2020 Dec 04.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Aurora Kinase A/*metabolism
    Aurora Kinase B/*metabolism
    Precursor Cell Lymphoblastic Leukemia-Lymphoma/*enzymology
    Biomarkers, Tumor/metabolism ; Brazil/epidemiology ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Fusion Proteins, bcr-abl/metabolism ; Humans ; Infant ; K562 Cells ; Male ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality ; Protein Interaction Maps
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Leu124Serfs*26, a novel AGPAT2 mutation in congenital generalized lipodystrophy with early cardiovascular complications.
    Autorzy:
    Montenegro Junior RM; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Lima GEDCP; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Fernandes VO; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Montenegro APDR; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Ponte CMM; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Martins LV; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Pinheiro DP; 2Drug Research and Development Center-NPDM, Universidade Federal do Ceará, Fortaleza, Brazil.
    de Moraes MEA; 2Drug Research and Development Center-NPDM, Universidade Federal do Ceará, Fortaleza, Brazil.
    de Moraes Filho MO; 2Drug Research and Development Center-NPDM, Universidade Federal do Ceará, Fortaleza, Brazil.
    d'Alva CB; 1Brazilian Group for the Study of Inherited and Acquired Lipodystrophies (BRAZLIPO), Faculdade de Medicina, Universidade Federal do Ceará, Rua Professor Costa Mendes, 1608, Rodolfo Teófilo, Fortaleza, Ceará 60416200 Brazil.
    Pokaż więcej
    Źródło:
    Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2020 Apr 06; Vol. 12, pp. 28. Date of Electronic Publication: 2020 Apr 06 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Neovaginoplasty for radiation-induced vaginal stenosis using Nile Tilapia Fish Skin as a biological graft.
    Autorzy:
    Dias MTPM; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Bilhar APM; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Rios LC; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Costa BA; Drug Research and Development Center, Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Duete ÚR; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Lima Júnior EM; Burn Treatment Center, Dr. José Frota Institute, Fortaleza, Ceará, Brazil.
    Alves APNN; Nursing, Dentistry and Pharmacy School, Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Bruno ZV; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    de Moraes Filho MO; Drug Research and Development Center, Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Bezerra LRPS; Maternity School Assis Chateaubriand (MEAC), Federal University of Ceará (UFC), Fortaleza, Ceará, Brazil.
    Pokaż więcej
    Źródło:
    Journal of surgical case reports [J Surg Case Rep] 2019 Nov 20; Vol. 2019 (11), pp. rjz311. Date of Electronic Publication: 2019 Nov 20 (Print Publication: 2019).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Innovative treatment using tilapia skin as a xenograft for partial thickness burns after a gunpowder explosion.
    Autorzy:
    Lima-Junior EM; Burn Treatment Center, Dr. José Frota Institute, 60025-061, Fortaleza, CE, Brazil.
    de Moraes Filho MO; Clinical Pharmacology Unit, Drug Research and Development Center, 60430-275, Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
    Costa BA; Clinical Pharmacology Unit, Drug Research and Development Center, 60430-275, Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
    Fechine FV; Clinical Pharmacology Unit, Drug Research and Development Center, 60430-275, Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
    de Moraes MEA; Clinical Pharmacology Unit, Drug Research and Development Center, 60430-275, Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
    Silva-Junior FR; Burn Treatment Center, Dr. José Frota Institute, 60025-061, Fortaleza, CE, Brazil.
    Soares MFADN; Burn Treatment Center, Dr. José Frota Institute, 60025-061, Fortaleza, CE, Brazil.
    Rocha MBS; Clinical Pharmacology Unit, Drug Research and Development Center, 60430-275, Federal University of Ceará (UFC), Fortaleza, CE, Brazil.
    Leontsinis CMP; Burn Treatment Center, Dr. José Frota Institute, 60025-061, Fortaleza, CE, Brazil.
    Pokaż więcej
    Źródło:
    Journal of surgical case reports [J Surg Case Rep] 2019 Jun 14; Vol. 2019 (6), pp. rjz181. Date of Electronic Publication: 2019 Jun 14 (Print Publication: 2019).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The impact of lung cancer resection surgery on fibrinogen and C-reactive protein and their relationship with patients outcomes: A prospective follow up study.
    Autorzy:
    Araújo AS; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.
    Nogueira IC; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.
    Gomes Neto A; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.
    de Medeiros IL; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.
    Morano MT; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.; Universidade de Fortaleza - UNIFOR, Fortaleza, Brazil.
    da Silva GP; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.; Universidade de Fortaleza - UNIFOR, Fortaleza, Brazil.
    Santos FA; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.
    De Moraes Filho MO; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.
    Pereira ED; Universidade Federal do Ceará - UFC, Fortaleza, Brazil.; Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, Brazil.
    Pokaż więcej
    Źródło:
    Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2016; Vol. 16 (1), pp. 47-53.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    C-Reactive Protein*
    Fibrinogen*
    Biomarkers/*blood
    Lung Neoplasms/*blood
    Lung Neoplasms/*surgery
    Aged ; Combined Modality Therapy ; Comorbidity ; Cytokines/blood ; Female ; Follow-Up Studies ; Humans ; Inflammation Mediators/blood ; Lung Neoplasms/diagnosis ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Staging ; Prospective Studies ; Respiratory Function Tests ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Autorzy:
    Faria MH; Department of Pathology and Forensic Medicine, Universidade Federal do Ceará, Fortaleza, Brazil.
    Neves Filho EH
    Alves MK
    Burbano RM
    de Moraes Filho MO
    Rabenhorst SH
    Pokaż więcej
    Źródło:
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2012 Nov; Vol. 120 (11), pp. 882-9. Date of Electronic Publication: 2012 May 18.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Genes, p53*
    Mutation*
    Astrocytoma/*genetics
    Astrocytoma/*pathology
    Tumor Suppressor Protein p53/*metabolism
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Astrocytoma/metabolism ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Child ; Child, Preschool ; Codon ; DNA, Neoplasm/genetics ; Exons ; Female ; Humans ; Male ; Middle Aged ; Polymorphism, Genetic ; Sequence Analysis, DNA ; Tumor Suppressor Protein p53/genetics ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Autorzy:
    Faria MH; Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. />Gonçalves BP
    do Patrocínio RM
    de Moraes-Filho MO
    Rabenhorst SH
    Pokaż więcej
    Źródło:
    Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2006 Dec; Vol. 26 (6), pp. 519-27.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Astrocytoma/*metabolism
    Astrocytoma/*pathology
    Biomarkers, Tumor/*metabolism
    Brain Neoplasms/*metabolism
    Brain Neoplasms/*pathology
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, Neoplasm/metabolism ; Cell Division ; Child ; Child, Preschool ; DNA Topoisomerases, Type II/metabolism ; DNA-Binding Proteins/metabolism ; Female ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Humans ; Immunohistochemistry ; Infant ; Ki-67 Antigen/metabolism ; Male ; Middle Aged ; Prognosis ; Proto-Oncogene Proteins c-myc/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-13 z 13

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies